ask="12.41"
ask_size="200"
average_daily_volume="1606400"
bid="9.82"
bid_size="200"
book_value="-0.09"
change="-0.06"
change_from_200_day_moving_average="-0.52"
change_from_50_day_moving_average="-1.81"
change_from_52_week_high="-7.63"
change_From_52_week_low="2.92"
change_in_percent="-0.60%"
close="9.88"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.56"
ebitda="-52.95M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.73"
ex_dividend_date="N/A"
float_shares="94960000"
high="10.14"
high_52_weeks="17.51"
last_trade_date="12/30/2016"
last_trade_price="9.88"
last_trade_size="76913"
last_trade_time="4:00pm"
low="9.81"
low_52_weeks="6.96"
market_capitalization="1.27B"
moving_average_200_day="10.40"
moving_average_50_day="11.69"
name="Halozyme Therapeutics
Inc."
notes="N/A"
one_year_target_price="14.22"
open="9.95"
pe_ratio="N/A"
peg_ratio="-0.24"
percent_change_from_200_day_moving_average="-5.01%"
percent_change_from_50_day_moving_average="-15.45%"
percent_change_from_52_week_high="-43.58%"
percent_change_from_52_week_low="+41.95%"
previous_close="9.94"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="7.97"
revenue="159.91M"
shares_outstanding="128154000"
short_ratio="15.05"
stock_exchange="NMS"
symbol="HALO"
volume="878163"
weeks_range_52="6.96 - 17.51"
